Latest News from ASCO in Action

Latest News from ASCO in Action

August 18, 2014

ASCO, in a letter to Senate Finance Committee Chair Ron Wyden (D-Ore.) and committee member Charles Grassley (R-Iowa), responded to their recommendations on enhancing the availability and utility of health care data, while strictly maintaining and protecting patient privacy. The letter expressed ASCO’s support for data transparency and the society’s interest in working with policymakers to enhance the quality and value of the care provided to cancer patients. Additionally, it outlined some of the society’s key initiatives including the Quality Oncology Practice Initiative (QOPI) and its participation in the American Board of Internal Medicine’s “Choosing Wisely” campaign.

August 18, 2014

ASCO will be hosting a FREE webinar about CMS Reporting, QOPI, and how to meet PQRS requirements through QOPI on Monday, September 8th at 4:00 PM ET.

August 15, 2014

On August 14, 2014, the U. S. Food and Drug Administration approved bevacizumab solution for intravenous infusion (Avastin®, Genentech, Inc.) for the treatment of persistent, recurrent or metastatic cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan.

ASCO's ACT Network

ASCO's ACT Network

ALERT CONGRESS TODAY! Use ASCO's ACT Network to contact your elected officials on important policy issues impacting cancer care. 

ASCO Issue Backgrounders

ASCO Issue Backgrounders

ASCO offers issue backgrounders to help provide an overview of the major policy issues that impact patients with cancer and the physicians who care for them. The issue backgrounders cover topics such as reimbursement, health equity, cancer research funding, and more.

Click here to read the backgrounds and help develop your understanding of cancer policy issues.

NIH Funding Educational Series

NIH Funding Educational Series

ASCO explores the decade-long decline in federal funding for cancer research – and why this decline must be reversed. Read more here.